{"id":"https://openalex.org/W2087634902","doi":"https://doi.org/10.1097/01.aids.0000191232.16111.f9","title":"Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme","display_name":"Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme","alternate_titles":[],"publication_year":2005,"publication_date":"2005-10-31","ids":{"openalex":"https://openalex.org/W2087634902","doi":"https://doi.org/10.1097/01.aids.0000191232.16111.f9","mag":"2087634902","pmid":"https://pubmed.ncbi.nlm.nih.gov/16260920"},"language":"en","primary_location":{"id":"doi:10.1097/01.aids.0000191232.16111.f9","doi":"https://doi.org/10.1097/01.aids.0000191232.16111.f9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aids.0000191232.16111.f9","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2087634902"],"child_works_count":0,"type":"letter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047551582","display_name":"Stephen D Lawn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089966","display_name":"London School of Hygiene & Tropical Medicine","ror":"https://ror.org/00a0jsq62","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210089966"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen D Lawn","raw_affiliation_strings":["Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK","The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK","institution_ids":["https://openalex.org/I4210089966"]},{"raw_affiliation_string":"The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039983859","display_name":"Linda\u2010Gail Bekker","orcid":"https://orcid.org/0000-0002-0755-4386","observed_orcids":["https://orcid.org/0000-0002-0755-4386"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Linda-Gail Bekker","raw_affiliation_strings":["The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084732324","display_name":"Landon Myer","orcid":"https://orcid.org/0000-0002-8106-7658","observed_orcids":["https://orcid.org/0000-0002-8106-7658"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Landon Myer","raw_affiliation_strings":["Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa","The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]},{"raw_affiliation_string":"The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032374309","display_name":"Catherine Orrell","orcid":"https://orcid.org/0000-0003-1134-7475","observed_orcids":["https://orcid.org/0000-0003-1134-7475"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine Orrell","raw_affiliation_strings":["The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064614188","display_name":"Robin Wood","orcid":"https://orcid.org/0000-0002-4276-7117","observed_orcids":["https://orcid.org/0000-0002-4276-7117"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robin Wood","raw_affiliation_strings":["The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":135,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"17","first_page":"2050","last_page":"2052"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12369","display_name":"Pneumocystis jirovecii pneumonia detection and treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cryptococcal-meningitis","display_name":"cryptococcal meningitis","score":0.984000027179718},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/early-mortality","display_name":"early mortality","score":0.7699999809265137},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.335999995470047},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.6639999747276306},{"id":"https://openalex.org/keywords/fluconazole-prophylaxis","display_name":"fluconazole prophylaxis","score":0.7450000047683716},{"id":"https://openalex.org/keywords/central-nervous-system-cryptococcosis","display_name":"central nervous system cryptococcosis","score":0.6399999856948853},{"id":"https://openalex.org/keywords/south-africa","display_name":"South Africa","score":0.4959999918937683},{"id":"https://openalex.org/keywords/who-treatment-guidelines","display_name":"WHO treatment guidelines","score":0.6019999980926514},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.6499999761581421},{"id":"https://openalex.org/keywords/aids-defining-illness","display_name":"AIDS-defining illness","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.816041886806488},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7440292835235596},{"id":"https://openalex.org/C2781026528","wikidata":"https://www.wikidata.org/wiki/Q48143","display_name":"Meningitis","level":2,"score":0.5267581343650818},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.48461422324180603},{"id":"https://openalex.org/C3019493264","wikidata":"https://www.wikidata.org/wiki/Q1470140","display_name":"Cryptococcal meningitis","level":4,"score":0.4655305743217468},{"id":"https://openalex.org/C2779413141","wikidata":"https://www.wikidata.org/wiki/Q1470140","display_name":"Cryptococcosis","level":2,"score":0.4295985698699951},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41603022813796997},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.41265565156936646},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3901846706867218},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3845441937446594},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24919968843460083},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.23256605863571167},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.12418800592422485},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.11136245727539062}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013019","descriptor_name":"South Africa","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016919","descriptor_name":"Meningitis, Cryptococcal","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D017088","descriptor_name":"AIDS-Related Opportunistic Infections","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/01.aids.0000191232.16111.f9","doi":"https://doi.org/10.1097/01.aids.0000191232.16111.f9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aids.0000191232.16111.f9","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:16260920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16260920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Comment"},{"id":"pmh:oai:researchonline.lshtm.ac.uk:12509","doi":null,"is_oa":false,"landing_page_url":"http://researchonline.lshtm.ac.uk/id/eprint/12509/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402527","display_name":"LSHTM Research Online (London School of Hygiene and Tropical Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210089966","host_organization_name":"London School of Hygiene & Tropical Medicine","host_organization_lineage":["https://openalex.org/I4210089966"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1944191141","https://openalex.org/W1963966543","https://openalex.org/W2066299927","https://openalex.org/W2072662158","https://openalex.org/W2089438995","https://openalex.org/W2141305342","https://openalex.org/W2148847506","https://openalex.org/W4233381066"],"related_works":["https://openalex.org/W2023120692","https://openalex.org/W2125755974","https://openalex.org/W2400327790","https://openalex.org/W2113417401","https://openalex.org/W2081132209","https://openalex.org/W2081488265","https://openalex.org/W2107134337","https://openalex.org/W2803792821","https://openalex.org/W2894597244","https://openalex.org/W1988149075"],"abstract_inverted_index":{"We":[0,52,645],"read":[1],"with":[2,168,403,418,493,565,570,604,679,700],"interest":[3],"the":[4,27,39,106,137,156,188,220,232,240,252,290,308,325,333,363,367,378,385,390,393,422,442,497,507,518,535,560,578,591,594,614,637,640,648,658,665,671,690,712,727,739,743,749,787,792,797,800,809],"recent":[5],"paper":[6],"by":[7,176,477,613,783,808],"Lortholary":[8],"et":[9],"al.":[10],"[1]":[11],"describing":[12],"cryptococcocal":[13,42],"immune":[14,337],"reconstitution":[15],"disease":[16,218,248,282,297,587],"(IRD)":[17],"in":[18,44,58,140,185,425,449,547,550,559,590,635,724,735],"France.":[19],"This":[20],"is":[21,416,428,540,588,602,608,617,622,806],"an":[22,341,685],"increasingly":[23,544],"recognized":[24],"complication":[25],"of":[26,30,41,122,149,158,197,200,219,229,234,246,254,280,289,302,312,316,319,328,336,343,350,369,373,376,388,407,499,526,568,581,597,611,650,660,673,683,687,692,726,745,751,763,789,794,799,802],"initial":[28,326,386,641],"weeks":[29,174,327,387],"antiretroviral":[31,329],"treatment":[32,81,603,642,655,744],"(ART)":[33],"[1\u20135].":[34],"However,":[35,718,738],"to":[36,78,161,340,437,440,542,697,710,754,766,780],"our":[37,426],"knowledge,":[38],"frequency":[40],"IRD":[43,361,462,478,485,500,532,539,674,765,778],"low-income":[45,736],"countries":[46],"has":[47,629],"not":[48],"previously":[49,351],"been":[50],"reported.":[51],"run":[53],"a":[54,147,195,404,432,524,618,680,701],"community-based":[55],"ART":[56,76,230,446,548,557,693,733,752],"programme":[57],"Gugulethu,":[59],"Cape":[60],"Town,":[61],"South":[62],"Africa":[63,552],"[6].":[64],"Between":[65],"September":[66],"2002":[67,80],"and":[68,105,131,243,272,295,397,430,748,757,770,796],"November":[69],"2004,":[70],"434":[71],"treatment-naive":[72],"patients":[73,124,204,292,448,509,569,575],"started":[74],"triple-drug":[75],"according":[77],"WHO":[79,127],"guidelines":[82],"[7].":[83],"The":[84,226],"patients\u2019":[85],"mean":[86],"age":[87],"was":[88,97,111,136,166,191,236,257,362,533],"34":[89],"years,":[90],"their":[91,457,527],"median":[92,107,148,189,227],"blood":[93],"CD4":[94],"cell":[95],"count":[96],"86":[98],"cells/\u03bcl":[99],"[interquartile":[100],"range":[101],"(IQR)":[102],"46\u2013146":[103],"cells/\u03bcl],":[104],"plasma":[108],"HIV":[109],"load":[110],"76":[112],"337":[113],"copies/ml":[114],"(IQR":[115],"32":[116],"723\u2013192":[117],"772":[118],"copies/ml).":[119],"A":[120],"total":[121,196,304],"137":[123],"(32%)":[125],"had":[126,512],"stage":[128],"4":[129,237],"disease,":[130],"among":[132,447],"these":[133,374],"cryptococcal":[134,164,217,281,296,586,600,661,746,764,777],"meningitis":[135,165,601,747],"AIDS-defining":[138],"illness":[139],"18":[141],"(13%).":[142],"These":[143],"diagnoses":[144,501],"were":[145,522],"made":[146,761],"7":[150],"months":[151,245,311],"(range":[152],"2\u201324":[153],"months)":[154],"before":[155,689,715],"initiation":[157,691,750],"ART.":[159,287,676,717,803],"According":[160],"national":[162],"guidelines,":[163],"treated":[167,345],"fluconazole":[169],"400":[170],"mg/day":[171,178],"for":[172,299,553,599,653,776],"8":[173],"followed":[175],"200":[177],"as":[179,625],"secondary":[180,626],"prophylaxis.":[181],"At":[182],"data":[183],"censorship":[184],"February":[186],"2005,":[187],"follow-up":[190],"46":[192],"weeks.":[193,238],"During":[194],"460":[198],"person-years":[199],"observation":[201],"(PYO),":[202],"nine":[203,291,317,508],"developed":[205,410],"either":[206,474],"recurrent":[207],"(n":[208,213],"=":[209,214],"6)":[210],"or":[211,348,371,456,479],"new":[212,482],"3)":[215],"symptomatic":[216],"central":[221,320],"nervous":[222,321],"system":[223,322],"(Table":[224],"1).":[225],"duration":[228],"at":[231,577],"onset":[233,256],"symptoms":[235,472],"In":[239],"first,":[241],"second":[242],"third":[244],"ART,":[247,389],"incidence":[249,381],"based":[250],"upon":[251],"time":[253],"symptom":[255],"18.2":[258],"cases/100":[259,267,274],"PYO":[260,268],"[95%":[261],"confidence":[262],"interval":[263,741],"(CI)":[264],"8.2\u201340.6],":[265],"6.2":[266],"(95%":[269],"CI":[270],"1.6\u201325.1)":[271],"0":[273],"PYO,":[275],"respectively.":[276],"Only":[277],"one":[278],"case":[279,486],"occurred":[283],"after":[284],"12":[285],"weeks\u2019":[286],"Six":[288],"(66%)":[293],"died":[294],"accounted":[298],"six":[300],"out":[301],"22":[303],"deaths":[305],"(27%)":[306],"during":[307,324,445,639,675],"first":[309],"3":[310],"ART.Table":[313],"1:":[314],"Features":[315],"cases":[318,375,465,492,521],"cryptococcosis":[323],"treatment.IRD":[330],"results":[331],"from":[332,466,517],"rapid":[334,395],"restoration":[335],"function,":[338],"leading":[339],"exacerbation":[342],"partly":[344],"opportunistic":[346,483],"infections":[347,354],"unmasking":[349],"undiagnosed":[352],"subclinical":[353],"[8].":[355,463],"Several":[356],"factors":[357],"have":[358],"suggested":[359,530],"that":[360,435,488,531,647],"likely":[364,541],"mechanism":[365],"underlying":[366,536],"presentation":[368,529],"most":[370],"all":[372],"cryptococcosis:":[377],"very":[379,571],"high":[380],"density":[382],"rate":[383,424],"within":[384,664],"sudden":[391],"onset,":[392],"typically":[394],"evolution":[396],"fulminant":[398],"clinical":[399,528],"course.":[400],"Of":[401,506],"those":[402,678,699],"previous":[405,681],"history":[406,682],"cryptococcosis,":[408,684],"one-third":[409],"probable":[411],"IRD.":[412,583],"Although":[413],"this":[414,651,719],"proportion":[415],"comparable":[417],"other":[419],"series":[420,427],"[2,5],":[421],"mortality":[423,444],"higher":[429],"represents":[431],"substantial":[433],"problem":[434],"needs":[436,753],"be":[438,475,543,695,708,722,755,760,781],"addressed":[439],"reduce":[441,711],"early":[443,768],"resource-limited":[450],"settings.":[451],"Live":[452],"organisms,":[453],"dead":[454],"organisms":[455,469],"shed":[458],"antigens":[459],"may":[460,473,503,656,721],"trigger":[461],"Among":[464,677],"whom":[467],"viable":[468],"are":[470,562,576],"cultured,":[471],"caused":[476],"simply":[480],"represent":[481],"disease.":[484],"definitions":[487],"exclude":[489],"clinically":[490],"suspected":[491],"positive":[494],"cultures":[495,516],"increase":[496,657],"specificity":[498],"but":[502,628],"limit":[504],"sensitivity.":[505],"described,":[510],"seven":[511],"sterile":[513],"cultures;":[514],"although":[515],"remaining":[519],"two":[520],"positive,":[523],"review":[525],"potentially":[534],"mechanism.":[537],"Cryptococcocal":[538],"frequently":[545],"encountered":[546],"programmes":[549,558,734],"sub-Saharan":[551],"several":[554],"reasons.":[555],"First,":[556],"region":[561],"currently":[563],"inundated":[564],"large":[566],"numbers":[567],"advanced":[572],"immunodeficiency;":[573],"such":[574],"greatest":[579],"risk":[580,659,672],"developing":[582],"Second,":[584],"HIV-associated":[585],"common":[589],"region.":[592],"Third,":[593],"local":[595],"standard":[596],"care":[598],"oral":[605],"fluconazole,":[606],"which":[607,621],"supplied":[609],"free":[610],"charge":[612],"manufacturer.":[615],"Fluconazole":[616],"fungistatic":[619],"drug,":[620],"broadly":[623],"effective":[624],"prophylaxis,":[627],"far":[630],"less":[631],"efficacy":[632],"than":[633],"amphotericin":[634],"clearing":[636],"organism":[638],"phase":[643],"[9].":[644],"suggest":[646],"use":[649,793],"agent":[652],"primary":[654],"antigen":[662,703],"persistence":[663],"cerebrospinal":[666],"fluid":[667],"(CSF),":[668],"possibly":[669],"increasing":[670],"analysis":[686],"CSF":[688],"might":[694,706],"used":[696],"identify":[698],"persistent":[702],"burden":[704,714],"who":[705],"then":[707],"retreated":[709],"fungal":[713],"starting":[716],"strategy":[720],"impractical":[723],"view":[725],"huge":[728],"logistic":[729],"challenges":[730],"facing":[731],"many":[732],"countries.":[737],"optimum":[740],"between":[742],"defined,":[756],"clinicians":[758],"should":[759],"aware":[762],"promote":[767],"diagnosis":[769],"prompt":[771],"treatment.":[772],"Optimal":[773],"management":[774],"strategies":[775],"need":[779],"defined":[782],"future":[784],"studies,":[785],"including":[786],"choice":[788],"antifungal":[790],"agents,":[791],"corticosteroids,":[795],"role":[798],"discontinuation":[801],"Sponsorship:":[804],"S.D.L.":[805],"funded":[807],"Wellcome":[810],"Trust,":[811],"London.":[812]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2087634902","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
